American College Of Rheumatology 2016 News

news

Patients with clinically suspect arthralgia who have circulating anti-citrullinated protein antibodies (ACPAs) and rheumatoid factor (RF) are at an increased risk of clinical arthritis progression, according to research presented at the American College of Rheumatology 2016 annual meeting. Robin M ten Brinck, PhD candidate from the Department of Rheumatology at Leiden University Medical Center, the…

news

WASHINGTON, DC — Researchers evaluating the 3-year efficacy of secukinumab found that it safe and efficacious in the treatment of psoriatic arthritis (PsA) across multiple dosages, according to recent research recently presented at the American College of Rheumatology 2016 annual meeting. Philip J Mease, MD, from the Swedish Medical Center and University of Washington, Seattle,…

news

WASHINGTON, DC — Treatment of psoriatic arthritis (PsA) with ixekizumab (IXE)—an IgG4 monoclonal antibody—significantly improves arthritis, dactylitis and enthesitis at 52-weeks, according to research presented at the 2016 American College of Rheumatology Annual Meeting. Philip J Mease, MD, at the Swedish Medical Center and the University of Washington, and colleagues conducted a phase 3 study…

news

WASHINGTON, DC — There was no change in safety profile for adalimumab in pediatric patients with polyarticular juvenile idiopathic arthritis (pJIA), enthesitis-related arthritis (ERA), psoriasis (Ps), and Crohn’s disease (CD), a recent analysis showed. The research was presented at the American College of Rheumatology (ACR) 2016 Annual Meeting. Gerd Horneff, MD, from the Asklepios Kliniken GmbH…

news

WASHINGTON, DC — While it is established that interstitial lung disease (ILD) is linked with higher morbidity in patients with rheumatoid arthritis (RA), insights into the long-term progression of pulmonary impairment in such patients are lacking. Findings to be presented at the 2016 annual meeting of the American College of Rheumatology (ACR) will offer some initial…